本页面由Tiger Trade Technology Pte. Ltd.提供服务

Lyra Therapeutics

3.62
+0.02000.56%
盘后3.620.00000.00%16:41 EST
成交量:2.39万
成交额:8.73万
市值:642.51万
市盈率:-0.12
高:3.74
开:3.63
低:3.60
收:3.60
52周最高:37.50
52周最低:2.84
股本:177.49万
流通股本:132.37万
量比:0.81
换手率:1.81%
股息:- -
股息率:- -
每股收益(TTM):-29.4017
每股收益(LYR):-71.7474
净资产收益率:-404.48%
总资产收益率:-33.08%
市净率:-1.48
市盈率(LYR):-0.05

数据加载中...

2024/04/30

重要事件披露

Form 8-K - Current report
2024/04/19

重要事件披露

Form 8-K - Current report
2024/03/28

SEC问询函

Form CORRESP - Correspondence
2024/03/22

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/03/22

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/03/21

重要事件披露

Form 8-K - Current report
2024/03/01

重要事件披露

Form 8-K - Current report
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/13

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/01/08

重要事件披露

Form 8-K - Current report
2023/12/28

重要事件披露

Form 8-K - Current report
2023/12/19

重要事件披露

Form 8-K - Current report
2023/11/17

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/11/07

重要事件披露

Form 8-K - Current report
2023/11/07

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/09/13

重要事件披露

Form 8-K - Current report